Trials / Completed
CompletedNCT03328507
A Pilot Evaluation of BLI4900 Bowel Preparation in Adult Subjects
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 121 (actual)
- Sponsor
- Braintree Laboratories · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the safety and efficacy of BLI4900 as a bowel preparation prior to colonoscopy in adult patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BLI4900 | BLI4900 Bowel Preparation |
| DRUG | PEG Control | Polyethylene glycol-based bowel preparation |
Timeline
- Start date
- 2017-11-09
- Primary completion
- 2019-11-12
- Completion
- 2019-11-12
- First posted
- 2017-11-01
- Last updated
- 2023-10-24
- Results posted
- 2023-10-24
Locations
4 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03328507. Inclusion in this directory is not an endorsement.